← Back to Clinical Trials
Recruiting NCT06718842

NCT06718842 Walking Program in Fatty Liver Children With Phenylketonuria

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06718842
Status Recruiting
Phase —
Sponsor Cairo University
Condition Phenylketonurias
Study Type INTERVENTIONAL
Enrollment 40 participants
Start Date 2024-09-15
Primary Completion 2025-01-30

Trial Parameters

Condition Phenylketonurias
Sponsor Cairo University
Study Type INTERVENTIONAL
Phase N/A
Enrollment 40
Sex ALL
Min Age 9 Years
Max Age 12 Years
Start Date 2024-09-15
Completion 2025-01-30
Interventions
walking free online supervised program

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

phenylketonuria (commonly known as PKU) is an inherited disorder that increases the levels of a substance called phenylalanine in the blood. PKU is usually associated with many metabolic complication including non-alcoholic fatty liver

Eligibility Criteria

Inclusion Criteria: * PKU children * obese children * fatty liver children (non-alcoholic fatty liver) Exclusion Criteria: * cardiac children * diabetic children * neurogenic disorders * respiratory and renal problems

Related Trials

VIEW ON CLINICALTRIALS.GOV ↗ MORE PHENYLKETONURIAS TRIALS
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology